Pfizer (NYSE:PFE) - Page 2

10 Stocks Analysts Want You to Sell

Now that the bull market is more than eight years old and many of the pro-growth policies out of Washington may be muted or delayed, many investors are wondering how they ...
Read Full Story »

UnitedHealth, Nike Weigh on DJIA Tuesday

May 16, 2017: Markets opened higher again Tuesday but none of the indexes was able to remain above the breakeven line for the whole day. Home Depot's earnings were better ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AIG, Exact Sciences, MercadoLibre, Pfizer, Whole Foods, Valero Energy, Yum Brands and More

Stocks were indicated to open higher yet again on Tuesday, even after the gains seen on Monday. The major market indexes are all at or right within striking distance of ...
Read Full Story »

Top Credit Suisse Pharma Picks Ahead of Catalysts

Credit Suisse analyst Vamil Divan has released an outlook on the pharmaceutical sector. While the weighting for the sector is Market Weight, there are some positives in the call. The ...
Read Full Story »

Why Big Pharma Is Not at Fault for Record Drug Spending

With prescription drug spending breaking new records almost every year now, people like to blame Big Pharma and use it as the industry punching bag. But the truth is, Big ...
Read Full Story »

Why Sangamo Therapeutics Is Surging

Sangamo Therapeutics Inc. (NASDAQ: SGMO) saw its shares skyrocket early on Thursday after a critical business update. Although the company did recently report its first-quarter results, this is not what’s ...
Read Full Story »

Short Interest in Major Pharma Shrinks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Pfizer Sinks on Mixed Q1 Earnings

Pfizer Inc. (NYSE: PFE) reported its first-quarter financial results before the markets opened on Tuesday. The company posted $0.69 in earnings per share (EPS) and $12.78 billion in revenue, compared ...
Read Full Story »

What to Expect From Apple and More Dow Stocks Reporting on Tuesday

24/7 Wall St. has put together a preview of the Dow Jones Industrial Average companies scheduled to report their quarterly results on Tuesday. Most of the companies in the Dow ...
Read Full Story »

Facebook, Tesla and More Major Earnings Coming Out This Week

Over the course of this past week, markets were largely driven higher as the result of some amazing earnings. Roughly one-third of the Dow reported this past week, and the ...
Read Full Story »

Short Sellers Can’t Make Up Their Minds on Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Short Sellers Run for Cover From Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Apple, DuPont Sink DJIA Tuesday

April 11, 2017: Markets opened mixed Tuesday and investors' efforts to cross into positive territory mostly fell short. Among the 11 S&P sectors, only real estate posted a decent gain, ...
Read Full Story »

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

The 6 Most Shorted NYSE Stocks

March came in like a lamb, as far as the markets were concerned. With the major markets retreating from all-time highs, it began to look like the Trump rally was ...
Read Full Story »